InvestorsHub Logo
Followers 83
Posts 5662
Boards Moderated 1
Alias Born 10/17/2006

Re: Doc logic post# 118490

Sunday, 05/21/2017 2:04:32 PM

Sunday, May 21, 2017 2:04:32 PM

Post# of 699586
The average patient has progression after 1.7 months.

Nobody was allowed in the trial who had progression after two months.

Right from the beginning it is trivial to see that the sickest 50% of patients weren't allowed in the trial.

Now we just have to figure out if not allowing them in has any affect on how long the group is likely to survive. That's something to ponder.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News